|
Diabetes Medication Article
BYETTA - New Class of Diabetic Drug
Byetta is a drug derived from the saliva of the Gila monster lizard. I do know one person who is taking Byetta and has better control of her blood sugar levels. The medication has even decreased her appetite. That is a benefit for her since she is overweight.
Byetta (exenatide) is the first among a new class of diabetes drugs for Type 2 Diabetes called incretin mimetics -- synthetic medications that mimic action of a hormone that spurs insulin production after a person eats and blood sugar levels rise above a certain threshold.
Traditional diabetes drugs that promote insulin production do so even if glucose levels aren't high enough, which could cause hypoglycemia (dangerously low blood sugar).
Byetta, derived from the lizard's saliva, mimics that action of the human hormone GLP-1, which prompts the body to secrete insulin and is also thought to play a role in deciding when a person feels full. This is great because it almost acts like an appetite suppressant. Common side effects of the drug were nausea and decreased appetite.
Byetta is very unique and supposedly works in a different way than pills or insulin. By helping your body produce the right amount of insulin at the right time, Byetta helps take the guesswork out of type 2 diabetes.
Byetta is used in combination with Metformin (Glucophage) and Sulfonylurea like Amaryl® (glimepiride), Glucotrol® (glipizide), Micronase® (glyburide), and others.
Byetta is an injectable medication and comes in prefilled insulin pens where you just add a small needle and inject yourself.
The price tag is not small, but with the New Medicare Prescription Plan D, you can check out your prescription plan to see if this medication is covered.
If you are on oral diabetic medications and you are not controlled, this may be an option for you. Ask your doctor. It doesn't hurt to ask.
Please remember that primary physicians don't know everything. That is not saying they are not great doctors. No one person can know everything. Just like us nurses, some specialize in heart disease or diabetes or wound care, etc. That also applies to doctors.
If you have heart problems, you should probably get a referral to a cardiologist. The same thing with Diabetes. You may want to get a referral to an endocrinologist. Check with your primary doctor and see if a referral to an endocrinologist is right for you.
You can get more information about Byetta at http://www.byetta.com
F. Kuhn, RN
specializing in Diabetes
http://www.diabetestestingcenter.com
http://www.heartnewscenter.com
Diabetic Drugs News
diabetic Drugs
Any good doctor will know about a drug's side effects, both brand names and generics before they prescribe it. But a doctor may have no idea that your medication tastes like fish. Any good doctor will know about a drug's side effects, both brand ...
Read moreSurprise! Doctors Learn Some Drugs are Stinky - ABC News
WASHINGTON - The commonly used diabetes drug metformin stinks, literally, and this may explain why many patients stop taking it, U.S. doctors reported on Monday. The drug smells like fish or dirty socks to some people and this could account for the ...
Read moreStinky diabetes drug turns off patients - MSNBC
LA JOLLA, Calif., February 12, 2010 An international team of investigators at Sanford-Burnham Medical Research Institute (Sanford-Burnham, formerly Burnham Institute for Medical Research), Nijmegen Centre for Molecular Life Sciences and other ...
Read moreResearchers identify mechanism for Frank-Ter Haar syndrome - Genetic Engineering News
The now-second-largest pharmaceutical reported quarterly net income of $6.49 billion, nearly quadruple last year's income of $1.64 billion. But the results include several large one-time items. Excluding these, earnings per share were 79 cents ...
Read moreMerck Revenues Rise Smartly, but It's Still Planning More Layoffs - Daily Finance
San Diego has grown up into the world’s third-leading hub of life sciences over the past three decades. But what will the local life sciences landscape look like another two decades from now? Will the region have gained basic research prowess ...
Read moreWhat Will San Diego’s Biotech Hub Look Like in 20 Years? Xconomy ... - Xconomy
... expects stronger results in 2010's second half than the first half, when it will get hit with generic competition for Cozaar and Hyzaar, plus brain cancer drug Temodar ... major markets and has 20 drugs in late-stage testing. Sales from Schering ...
Read moreSchering-Plough purchase hikes Merck sales, profit - Forbes
WASHINGTON -- An immediate-release form of the anti-diabetic agent metformin has a dead fish odor that may cause patients to stop taking the drug, clinicians warned. Metformin is known to cause adverse gastrointestinal effects such as diarrhea ...
Read moreStinky Diabetes Drug May Result in Poor Adherence - MedPage Today
... clinical testing for the treatment and prevention of diabetes ... is a new drug. None of them were approved by the FDA, and their labels do not bear adequate directions for use. Therefore, they are also categorized as unapproved drugs and ...
Read moreDietary Supplement Scammer Pleads Guilty - consumer affairs.com
Activists, including the Environmental Working Group and the Natural Resources Defense Council, cite studies that link BPA to breast cancer, heart disease, diabetes and other health problems. Bans are "not necessary," says Steve Hentges, a BPA ...
Read moreBans sought for chemical BPA in baby, toddler products - WBIR
... diabetes treatments Januvia and Janumet jumped 43 percent in the fourth quarter to $760 million, even as the products began to face competition from a rival drug from Bristol-Myers Squibb Co and AstraZeneca Plc. The drugs' sales topped the ...
Read more